Beranda › Atrofi Otot Tulang Belakang › Texas › Houston
Uji klinis Atrofi Otot Tulang Belakang di Houston, TX
5 studi untuk Atrofi Otot Tulang Belakang mencari peserta di lokasi sekitar Houston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
Menerima pesertaFase 2
- Texas Children's Hospital (TCH)-Clinical Care Center (CCC), Houston
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
Menerima pesertaFase 2
- Texas Children's Hospital, Houston
A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
Menerima pesertaFase 1
- Texas Childrens Hospital Houston, Houston
Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
Menerima peserta
- Texas Children's Hospital, Houston
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Menerima pesertaStudi observasional
- Texas Children's Hospital, Houston
Uji klinis Atrofi Otot Tulang Belakang di kota lain
- Mountain View, CA9 studi
- New York City, NY9 studi
- Philadelphia, PA7 studi
- Chicago, IL6 studi
- Norfolk, VA6 studi
- Grand Rapids, MI6 studi
- Boston, MA5 studi
- Little Rock, AR4 studi
- Lewisville, TX4 studi
- Phoenix, AZ4 studi
- Aurora, CO4 studi
- Memphis, TN3 studi
Studi lain di Houston
- Kanker Paru Non-Sel Kecil145 studi
- Kanker Payudara126 studi
- Kanker (semua jenis)121 studi
- Kanker Metastatik104 studi
- Kanker Kolorektal102 studi
- Kanker Ovarium89 studi
- Leukemia Mieloid Akut85 studi
- Kanker Paru78 studi
- Kanker Prostat76 studi
- Kanker Endometrium68 studi
- Kanker Pankreas61 studi
- Melanoma59 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.